- October 19, 2021
Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
The collaboration will integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management® (PTM) platform. This will enable both parties...
- October 12, 2021
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
Together, Körber and Vineti will streamline process development, operations, and manufacturing to deliver advanced therapies to patients in need around...
- August 12, 2021
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will...
- August 10, 2021
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients...
- May 26, 2021
Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies
Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain.
- May 10, 2021
Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution
SAN FRANCISCO, May 10, 2021 (GLOBE NEWSWIRE) -- Vineti, the developer of the leading digital platform of record for personalized therapeutics, today announced the release…
- February 5, 2020
Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics
- December 22, 2019
- December 17, 2019
- December 3, 2019
- December 2, 2019
- November 6, 2019